VIR-8190

N/A

Report date: 2023/08/24 17:16:47

Base Information

Drug NameVIR-8190
Drug Alias NameVIR-8190
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionVirus internalization inhibitors
TargetsUpdating
Therapy Area/IndicationsMetapneumovirus infectionsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcVir Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesVir Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsMetapneumovirus infectionsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A